Latest Non Dilutive Funding News

Heavy Minerals Limited has formalised a binding agreement with Hillgrove Resources to develop a pioneering garnet extraction project at the Kanmantoo Copper Mine, aiming to start production in late 2026.

Actinogen Medical has locked in a $4.3 million tranche of non-dilutive funding to support its pivotal Alzheimer’s disease trial, reinforcing its financial position as it nears critical interim and final results.

Nova Minerals has secured US$43.4 million in non-dilutive funding from the U.S. Department of War to fully fund its domestic antimony supply chain development in Alaska, while also progressing its vast Estelle gold project with promising drilling results.

Island Pharmaceuticals has secured key regulatory milestones for its antiviral Galidesivir, including FDA confirmation of the Animal Rule pathway and Priority Review Voucher eligibility, while strengthening US biodefense ties and expanding patent protection.

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

Pivotal Metals has raised $5.4 million, including $1.1 million in non-dilutive funding, to ramp up exploration across its Québec copper, gold, PGM, and nickel projects, unveiling multiple high-priority drill targets and advancing resource optimisation at Horden Lake.

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

Recce Pharmaceuticals has received a $5.3 million R&D tax rebate from the Australian Taxation Office, providing a significant cash injection to support its innovative synthetic anti-infective drug development programs.

BluGlass and North Carolina State University have secured a third-year contract extension worth A$1.05 million from the U.S. Department of War’s CLAWS Hub, reinforcing their role in advanced gallium nitride laser development for defence and quantum technologies.

Everest Metals Corporation has officially commenced mining operations at its Mt Dimer Taipan Gold Project in Western Australia, backed by a fully funded agreement with MEGA Resources. Ore extraction is underway with processing set to begin in March 2026, positioning the company for near-term cash flow.

Critical Resources has engaged SLR Consulting to streamline permitting for its Mavis Lake Lithium Project in Ontario, aiming to fast-track approvals and secure government funding. This move strengthens the project’s role in North America’s lithium supply chain amid growing demand for sustainable battery materials.

Invion Limited’s partner Hanlim Pharm, backed by South Korea’s government grant, has secured up to A$2 million in non-dilutive funding to advance preclinical studies of HL270 for oesophageal cancer, paving the way for human trials in Australia.